Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Analyst says buy Organigram given recent trends in adult-use sales » 13:54
07/09/20
07/09
13:54
07/09/20
13:54
OGI

Organigram

$1.50 /

-0.04 (-2.61%)

, IIPR

Innovative Industrial Properties

$90.25 /

-1 (-1.10%)

, GRWG

GrowGeneration

$6.65 /

-0.22 (-3.20%)

, ACB

Aurora Cannabis

$11.67 /

-0.455 (-3.75%)

, MMNFF

MedMen

$0.00 /

+ (+0.00%)

, NETP

Net Perceptions, Inc.

$0.00 /

+ (+0.00%)

, COST

Costco

$326.40 /

+10.025 (+3.17%)

, IFF

IFF

$121.61 /

-1.73 (-1.40%)

, CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$3.41 /

-0.02 (-0.58%)

, KERN

Akerna

$7.47 /

+0.005 (+0.07%)

, ALEAF

Aleafia Health

$0.00 /

+ (+0.00%)

, APHA

Aphria

$4.18 /

-0.145 (-3.36%)

, BIOIF

Biome Grow

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CGC

Canopy Growth

$16.00 /

-0.33 (-2.02%)

, CNPOF

Canopy Rivers

$0.00 /

+ (+0.00%)

, CRON

Cronos Group

$6.03 /

-0.165 (-2.66%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

, DYMEF

DionyMed Brands

$0.00 /

+ (+0.00%)

, ELLXF

Elixinol Global

$0.00 /

+ (+0.00%)

, FLURF

FluroTech

$0.00 /

+ (+0.00%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, GTBIF

Green Thumb Industries

$0.00 /

+ (+0.00%)

, GNLN

Greenlane

$3.29 /

-0.01 (-0.30%)

, HSDEF

Harborside

$0.00 /

+ (+0.00%)

, HEXO

Hexo

$0.74 /

+0.0444 (+6.42%)

, HEMP

Hemp, Inc.

$0.00 /

+ (+0.00%)

, IGC

India Globalization Capital

$0.56 /

+0.0048 (+0.86%)

, NDVAF

INDIVA

$0.00 /

+ (+0.00%)

, INDXF

Indus Holdings

$0.00 /

+ (+0.00%)

, WLDCF

ICC International Cannabis

$0.00 /

+ (+0.00%)

, KHRNF

Khiron Life Sciences

$0.00 /

+ (+0.00%)

, LHSIF

Liberty Health Sciences

$0.00 /

+ (+0.00%)

, MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

, MJARF

MJardin Group

$0.00 /

+ (+0.00%)

, ORHOF

Origin House

$0.00 /

+ (+0.00%)

, PLNHF

Planet 13 Holdings

$0.00 /

+ (+0.00%)

, RLBD

Real Brands

$0.00 /

+ (+0.00%)

, SRUTF

Sproutly

$0.00 /

+ (+0.00%)

, SNNVF

Sunniva

$0.00 /

+ (+0.00%)

, SPRWF

Supreme Cannabis

$0.00 /

+ (+0.00%)

, TBPMF

Tetra Bio Pharma

$0.00 /

+ (+0.00%)

, VLNCF

The Valens Company

$0.00 /

+ (+0.00%)

, TLRY

Tilray

$7.47 /

-0.12 (-1.58%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, VREOF

Vireo Health

$0.00 /

+ (+0.00%)

, MRRCF

Wayland Group

$0.00 /

+ (+0.00%)

, WDDMF

WeedMD

$0.00 /

+ (+0.00%)

, WLDFF

Wildflower Brands

$0.00 /

+ (+0.00%)

, YSSCF

YSS Corp.

$0.00 /

+ (+0.00%)

, FFNTF

4Front Ventures

$0.00 /

+ (+0.00%)

In this week's "Rising…

Open Full Text

ShowHide Related Items >><<
ZYNE Zynerba
$3.41 /

-0.02 (-0.58%)

WDDMF WeedMD
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

VREOF Vireo Health
$0.00 /

+ (+0.00%)

VLNCF The Valens Company
$0.00 /

+ (+0.00%)

TLRY Tilray
$7.47 /

-0.12 (-1.58%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

TBPMF Tetra Bio Pharma
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

SNNVF Sunniva
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

OGI Organigram
$1.50 /

-0.04 (-2.61%)

NDVAF INDIVA
$0.00 /

+ (+0.00%)

MRRCF Wayland Group
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

MJARF MJardin Group
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

KHRNF Khiron Life Sciences
$0.00 /

+ (+0.00%)

KERN Akerna
$7.47 /

+0.005 (+0.07%)

IIPR Innovative Industrial Properties
$90.25 /

-1 (-1.10%)

IGC India Globalization Capital
$0.56 /

+0.0048 (+0.86%)

IFF IFF
$121.61 /

-1.73 (-1.40%)

HSDEF Harborside
$0.00 /

+ (+0.00%)

HEXO Hexo
$0.74 /

+0.0444 (+6.42%)

HEMP Hemp, Inc.
$0.00 /

+ (+0.00%)

GTBIF Green Thumb Industries
$0.00 /

+ (+0.00%)

GRWG GrowGeneration
$6.65 /

-0.22 (-3.20%)

GNLN Greenlane
$3.29 /

-0.01 (-0.30%)

FLURF FluroTech
$0.00 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.03 /

-0.165 (-2.66%)

COST Costco
$326.40 /

+10.025 (+3.17%)

CNPOF Canopy Rivers
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$16.00 /

-0.33 (-2.02%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$4.18 /

-0.145 (-3.36%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

OGI Organigram
$1.50 /

-0.04 (-2.61%)

07/07/20 Alliance Global Partners
Organigram initiated with a Buy at Alliance Global Partners
06/29/20 Raymond James
Organigram downgraded to Market Perform from Outperform at Raymond James
06/29/20 Raymond James
Organigram downgraded to Market Perform from Outperform at Raymond James
04/15/20 CIBC
Organigram downgraded to Neutral from Outperformer at CIBC
IIPR Innovative Industrial Properties
$90.25 /

-1 (-1.10%)

07/06/20 Roth Capital
Innovative Industrial Properties price target raised to $120 from $110 at Roth Capital
06/23/20 Ladenburg
Innovative Industrial Properties price target raised to $104 from $83.50 at Ladenburg
05/21/20 Compass Point
Innovative Industrial price target raised to $100 from $75 at Compass Point
05/06/20 Ladenburg
Innovative Industrial price target raised to $83.50 from $69.50 at Ladenburg
GRWG GrowGeneration
$6.65 /

-0.22 (-3.20%)

07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
07/01/20 Roth Capital
GrowGeneration price target raised to $9 from $8 at Roth Capital
05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Benchmark
Benchmark starts 'dominant' B2B cannabis company GrowGeneration at Buy
ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

06/24/20
Fly Intel: Top five analyst upgrades
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/24/20 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/22/20 CIBC
Aurora Cannabis price target raised to C$24 from C$14 at CIBC
MMNFF MedMen
$0.00 /

+ (+0.00%)

05/29/20 Bryan Garnier
MedMen downgraded to Sell from Neutral at Bryan Garnier
05/28/20
MedMen downgraded to Sell from Hold at Canaccord
05/28/20 Canaccord
MedMen downgraded to Sell from Hold at Canaccord
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
NETP Net Perceptions, Inc.
$0.00 /

+ (+0.00%)

COST Costco
$326.40 /

+10.025 (+3.17%)

07/09/20 Oppenheimer
Costco price target raised to $355 from $335 at Oppenheimer
07/09/20 Cowen
Costco comps improved as categories stabilize, says Cowen
07/09/20 Loop Capital
Costco price target raised to $360 from $340 at Loop Capital
07/09/20 Nomura Instinet
Costco shares could rebound on June sales, says Nomura Instinet
IFF IFF
$121.61 /

-1.73 (-1.40%)

07/09/20
IFF initiated with an Overweight at Stephens
07/09/20 Stephens
IFF initiated with an Overweight at Stephens
06/22/20 Exane BNP Paribas
IFF downgraded to Underperform from Neutral at Exane BNP Paribas
04/29/20 Wells Fargo
IFF upgraded to Overweight from Equal Weight at Wells Fargo
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$3.41 /

-0.02 (-0.58%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
KERN Akerna
$7.47 /

+0.005 (+0.07%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

APHA Aphria
$4.18 /

-0.145 (-3.36%)

05/13/20 Cantor Fitzgerald
Aphria price target lowered to C$9.55 from C$9.85 at Cantor Fitzgerald
04/16/20 CIBC
Aphria price target lowered to C$6 from C$7 at CIBC
04/16/20 Canaccord
Aphria strong adult-use growth well-above expectations, says Canaccord
04/15/20 Alliance Global Partners
Aphria price target lowered to C$9 from C$11 at Alliance Global Partners
BIOIF Biome Grow
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

07/12/19
CannTrust downgraded to Sell from Neutral at Eight Capital
CGC Canopy Growth
$16.00 /

-0.33 (-2.02%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
CNPOF Canopy Rivers
$0.00 /

+ (+0.00%)

CRON Cronos Group
$6.03 /

-0.165 (-2.66%)

06/24/20 Raymond James
Cronos Group upgraded to Outperform from Market Perform at Raymond James
04/27/20 Raymond James
Cronos Group downgraded to Market Perform from Outperform at Raymond James
04/14/20 Piper Sandler
Piper Sandler downgrades Cronos to Neutral on delayed CBD launch
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
03/17/20 Roth Capital
CV Sciences downgraded to Neutral from Buy at Roth Capital
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

05/20/20 Canaccord
Delta 9 Cannabis upgraded to Speculative Buy from Hold at Canaccord
DYMEF DionyMed Brands
$0.00 /

+ (+0.00%)

ELLXF Elixinol Global
$0.00 /

+ (+0.00%)

FLURF FluroTech
$0.00 /

+ (+0.00%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
GTBIF Green Thumb Industries
$0.00 /

+ (+0.00%)

07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
05/18/20 Cantor Fitzgerald
Green Thumb Industries upgraded to Overweight at Cantor Fitzgerald on valuation
05/18/20 Cantor Fitzgerald
Green Thumb Industries upgraded to Overweight from Neutral at Cantor Fitzgerald
04/28/20
Fly Intel: Top five analyst initiations
GNLN Greenlane
$3.29 /

-0.01 (-0.30%)

03/31/20 Roth Capital
Greenlane price target lowered to $4 from $9 at Roth Capital
10/07/19 Roth Capital
Greenlane price target lowered to $10 from $18.50 at Roth Capital
HSDEF Harborside
$0.00 /

+ (+0.00%)

HEXO Hexo
$0.74 /

+0.0444 (+6.42%)

07/01/20 Bryan Garnier
Hexo downgraded to Sell from Buy at Bryan Garnier
06/29/20 BMO Capital
Hexo upgraded to Market Perform from Underperform at BMO Capital
06/11/20 Alliance Global Partners
Hexo continues to make strides in right direction, says Alliance Global Partners
04/15/20 Alliance Global Partners
Hexo price target lowered to C$1.50 from C$2.50 at Alliance Global Partners
HEMP Hemp, Inc.
$0.00 /

+ (+0.00%)

IGC India Globalization Capital
$0.56 /

+0.0048 (+0.86%)

NDVAF INDIVA
$0.00 /

+ (+0.00%)

INDXF Indus Holdings
$0.00 /

+ (+0.00%)

WLDCF ICC International Cannabis
$0.00 /

+ (+0.00%)

KHRNF Khiron Life Sciences
$0.00 /

+ (+0.00%)

LHSIF Liberty Health Sciences
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

08/07/19 Roth Capital
Medipharm Labs initiated with a Buy at Roth Capital
MJARF MJardin Group
$0.00 /

+ (+0.00%)

ORHOF Origin House
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

RLBD Real Brands
$0.00 /

+ (+0.00%)

SRUTF Sproutly
$0.00 /

+ (+0.00%)

SNNVF Sunniva
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

05/19/20 Stifel
Supreme Cannabis price target lowered to C$0.30 from C$0.50 at Stifel
05/19/20 CIBC
Supreme Cannabis price target lowered to C$0.35 from C$0.50 at CIBC
01/07/20 CIBC
Supreme Cannabis downgraded to Neutral from Outperformer at CIBC
TBPMF Tetra Bio Pharma
$0.00 /

+ (+0.00%)

VLNCF The Valens Company
$0.00 /

+ (+0.00%)

TLRY Tilray
$7.47 /

-0.12 (-1.58%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

06/22/20 AltaCorp
Trulieve Cannabis initiated with an Outperform at AltaCorp
04/06/20 Cantor Fitzgerald
Trulieve Cannabis price target raised to $32 from $30 at Cantor Fitzgerald
VREOF Vireo Health
$0.00 /

+ (+0.00%)

06/17/20 Canaccord
Vireo Health price target lowered to C$1.75 from C$2 at Canaccord
05/15/20 Eight Capital
Vireo Health downgraded to Neutral from Buy at Eight Capital
MRRCF Wayland Group
$0.00 /

+ (+0.00%)

WDDMF WeedMD
$0.00 /

+ (+0.00%)

WLDFF Wildflower Brands
$0.00 /

+ (+0.00%)

YSSCF YSS Corp.
$0.00 /

+ (+0.00%)

FFNTF 4Front Ventures
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$3.41 /

-0.02 (-0.58%)

WDDMF WeedMD
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

TLRY Tilray
$7.47 /

-0.12 (-1.58%)

OGI Organigram
$1.50 /

-0.04 (-2.61%)

MJARF MJardin Group
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

KERN Akerna
$7.47 /

+0.005 (+0.07%)

IIPR Innovative Industrial Properties
$90.25 /

-1 (-1.10%)

IFF IFF
$121.61 /

-1.73 (-1.40%)

HEXO Hexo
$0.74 /

+0.0444 (+6.42%)

GRWG GrowGeneration
$6.65 /

-0.22 (-3.20%)

GNLN Greenlane
$3.29 /

-0.01 (-0.30%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CRON Cronos Group
$6.03 /

-0.165 (-2.66%)

COST Costco
$326.40 /

+10.025 (+3.17%)

CGC Canopy Growth
$16.00 /

-0.33 (-2.02%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$4.18 /

-0.145 (-3.36%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

  • 30
    Jun
  • 30
    Jun
  • 27
    May
  • 19
    May
  • 24
    Jan
  • 12
    Jul
GTBIF Green Thumb Industries
$0.00 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

COST Costco
$326.40 /

+10.025 (+3.17%)

CGC Canopy Growth
$16.00 /

-0.33 (-2.02%)

ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

YSSCF YSS Corp.
$0.00 /

+ (+0.00%)

WLDFF Wildflower Brands
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

VLNCF The Valens Company
$0.00 /

+ (+0.00%)

TBPMF Tetra Bio Pharma
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

OGI Organigram
$1.50 /

-0.04 (-2.61%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

KERN Akerna
$7.47 /

+0.005 (+0.07%)

IIPR Innovative Industrial Properties
$90.25 /

-1 (-1.10%)

IFF IFF
$121.61 /

-1.73 (-1.40%)

HEXO Hexo
$0.74 /

+0.0444 (+6.42%)

GRWG GrowGeneration
$6.65 /

-0.22 (-3.20%)

GNLN Greenlane
$3.29 /

-0.01 (-0.30%)

FLURF FluroTech
$0.00 /

+ (+0.00%)

FFNTF 4Front Ventures
$0.00 /

+ (+0.00%)

COST Costco
$326.40 /

+10.025 (+3.17%)

CNPOF Canopy Rivers
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

TLRY Tilray
$7.47 /

-0.12 (-1.58%)

OGI Organigram
$1.50 /

-0.04 (-2.61%)

KERN Akerna
$7.47 /

+0.005 (+0.07%)

IFF IFF
$121.61 /

-1.73 (-1.40%)

HEXO Hexo
$0.74 /

+0.0444 (+6.42%)

GRWG GrowGeneration
$6.65 /

-0.22 (-3.20%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.03 /

-0.165 (-2.66%)

COST Costco
$326.40 /

+10.025 (+3.17%)

CGC Canopy Growth
$16.00 /

-0.33 (-2.02%)

APHA Aphria
$4.18 /

-0.145 (-3.36%)

ACB Aurora Cannabis
$11.67 /

-0.455 (-3.75%)

Over a week ago
Hot Stocks
MedMen announces lender and landlord support for turnaround plan » 11:10
07/03/20
07/03
11:10
07/03/20
11:10
MMNFF

MedMen

$0.00 /

+ (+0.00%)

MedMen Enterprises…

MedMen Enterprises announced the execution of definitive agreements with certain lenders, including Gotham Green Partners, Stable Road Capital and affiliates, and the company's "most significant landlord," Treehouse Real Estate Investment Trust, as part of a financial restructuring and turnaround plan to support the expansion of the company's retail footprint. The plan will defer approximately $32M in cash commitments over the next 12 months and provide additional balance sheet flexibility, the company said. As part of the plan announced today, the company and Gotham Green Partners have further amended and restated the securities purchase agreement that governs the convertible facility led by funds affiliated with GGP. In connection with the amendments to the convertible facility, the company is now subject to certain additional covenants thereunder, which are consistent with the company's internal business plan. The company is required to adhere to its turnaround plan for certain cash expenditures such as corporate expenses, capital expenditures and leases. The covenants expire once the company achieves two consecutive fiscal quarters of being free cash flow positive. "Implementing our turnaround plan is the best way to ensure that MedMen continues on its path to building the leading cannabis retailer in the U.S. We believe the widespread support we have received from our lenders and landlords will allow us to continue execution of the turnaround, continue to grow our best-in-class retail operations and drive towards positive free cash flow," said MedMen Interim CEO Tom Lynch.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

05/29/20 Bryan Garnier
MedMen downgraded to Sell from Neutral at Bryan Garnier
05/28/20
MedMen downgraded to Sell from Hold at Canaccord
05/28/20 Canaccord
MedMen downgraded to Sell from Hold at Canaccord
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
MMNFF MedMen
$0.00 /

+ (+0.00%)

Over a month ago
Downgrade
MedMen downgraded to Sell from Neutral at Bryan Garnier » 05:23
05/29/20
05/29
05:23
05/29/20
05:23
MMNFF

MedMen

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Bryan Garnier analyst Nikolaas Faes downgraded MedMen Enterprises to Sell from Neutral with a C$0.35 price target.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

05/28/20
MedMen downgraded to Sell from Hold at Canaccord
05/28/20 Canaccord
MedMen downgraded to Sell from Hold at Canaccord
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
MedMen initiated with a Neutral at Cantor Fitzgerald
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

Downgrade
MedMen downgraded to Sell from Hold at Canaccord » 10:38
05/28/20
05/28
10:38
05/28/20
10:38
MMNFF

MedMen

$0.00 /

+ (+0.00%)

As previously reported,…

As previously reported, Canaccord analyst Matt Bottomley downgraded MedMen to Sell from Hold with a price target of C$0.25, down from C$0.30 following the company's Q3 earnings results. The analyst sees near-term growth headwinds in the wake of the COVID-19 pandemic, along with a concerning balance sheet.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

05/28/20 Canaccord
MedMen downgraded to Sell from Hold at Canaccord
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
MedMen initiated with a Neutral at Cantor Fitzgerald
12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

Downgrade
MedMen downgraded to Sell from Hold at Canaccord » 05:24
05/28/20
05/28
05:24
05/28/20
05:24
MMNFF

MedMen

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Canaccord Genuity analyst Matt Bottomley downgraded MedMen Enterprises to Sell from Hold with a C$0.25 price target.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
MedMen initiated with a Neutral at Cantor Fitzgerald
12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
MMNFF MedMen
$0.00 /

+ (+0.00%)

MMNFF MedMen
$0.00 /

+ (+0.00%)

Over a quarter ago
Initiation
Cantor initiates 10 cannabis names, sees opportunity after sellofff » 07:33
02/14/20
02/14
07:33
02/14/20
07:33
TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, GGBXF

Green Growth Brands

$0.00 /

+ (+0.00%)

, MMNFF

MedMen

$0.00 /

+ (+0.00%)

, GTBIF

Green Thumb Industries

$0.00 /

+ (+0.00%)

, CURLF

Curaleaf Holdings

$0.00 /

+ (+0.00%)

, CRLBF

Cresco Labs

$0.00 /

+ (+0.00%)

, AYRSF

Ayr Strategies

$0.00 /

+ (+0.00%)

, ACRGF

Acreage Holdings

$0.00 /

+ (+0.00%)

, HRVSF

Harvest Health & Recreation

$0.00 /

+ (+0.00%)

, ITHUF

iAnthus

$0.00 /

+ (+0.00%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic launched coverage of 10 U.S. multi-state cannabis operators, saying the stocks are attractively valued with solid underlying industry fundamentals. He rates at Overweight Cresco Labs (CRLBF) and Trulieve Cannabis (TCNNF) and rates at Underweight Green Growth Brands (GGBXF). The analyst is Neutral on the rest of the space, but adds he will "keep an open mind." The Neutral ratings are on MedMen (MMNFF), Green Thumb Industries (GTBIF), Curaleaf Holdings (CURLF), Cresco Labs (CRLBF), Ayr Strategies (AYRSF), Acreage Holdings (ACRGF), Harvest Health & Recreation (HRVSF) and iAnthus (ITHUF). The current regulatory environment in key large U.S. "restricted" states provides a unique opportunity for multi-state operations to build out assets with a limited pool of competitors and be in a position of strength when full legalization comes, Zuanic tells investors in a research note. The boom and bust seen in Canadian stocks has, "unwarrantedly," dragged down U.S. MSOs and "masked strong underlying growth trends," contends the analyst. He believes this creates an attractive investment opportunity in the U.S. space.

ShowHide Related Items >><<
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Trulieve Cannabis initiated with an Overweight at Cantor Fitzgerald
12/16/19 Craig-Hallum
Trulieve Cannabis initiated with a Buy at Craig-Hallum
12/03/19 Needham
Trulieve Cannabis initiated with a Buy at Needham
12/02/19 Compass Point
Trulieve Cannabis upgraded to Buy from Neutral at Compass Point
GGBXF Green Growth Brands
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Green Growth Brands initiated with an Underweight at Cantor Fitzgerald
MMNFF MedMen
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
MedMen initiated with a Neutral at Cantor Fitzgerald
12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
10/29/19 Roth Capital
MedMen downgraded to Neutral from Buy at Roth Capital
GTBIF Green Thumb Industries
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Green Thumb Industries initiated with a Neutral at Cantor Fitzgerald
10/09/19 Craig-Hallum
Vaping crisis underscores need to lift cannabis prohibition, says Craig-Hallum
09/19/19 Alliance Global Partners
Green Thumb Industries initiated with a Buy at Alliance Global Partners
09/13/19
Fly Intel: Top five analyst initiations
CURLF Curaleaf Holdings
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Curaleaf Holdings initiated with a Neutral at Cantor Fitzgerald
12/03/19 Needham
Curaleaf Holdings initiated with a Buy at Needham
09/20/19 MKM Partners
MKM starts Curaleaf at Sell on concerns over Florida dependency
09/19/19 MKM Partners
Curaleaf Holdings initiated with a Sell at MKM Partners
CRLBF Cresco Labs
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Cresco Labs initiated with an Overweight at Cantor Fitzgerald
12/20/19 Roth Capital
Cresco Labs initiated with a Buy at Roth Capital
09/13/19 Cowen
Cresco Labs initiated with an Outperform at Cowen
08/13/19 Piper Sandler
Cresco Labs initiated with an Overweight at Piper Jaffray
AYRSF Ayr Strategies
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Ayr Strategies initiated with a Neutral at Cantor Fitzgerald
ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

02/13/20 Cantor Fitzgerald
Acreage Holdings initiated with a Neutral at Cantor Fitzgerald
10/31/19 Ladenburg
Cannabis sector investor sentiment is now 'very low,' says Ladenburg
09/20/19 MKM Partners
MKM starts Acreage at Buy on 'extreme disconnect' from Canopy offer
09/19/19 MKM Partners
Acreage Holdings initiated with a Buy at MKM Partners
HRVSF Harvest Health & Recreation
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
Harvest Health & Recreation initiated with a Neutral at Cantor Fitzgerald
07/08/19 Compass Point
Harvest Health & Recreation initiated with a Buy at Compass Point
ITHUF iAnthus
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
iAnthus initiated with a Neutral at Cantor Fitzgerald
02/21/19 Seaport Global
iAnthus initiated with a Buy at Seaport Global
Initiation
MedMen initiated with a Neutral at Cantor Fitzgerald » 16:10
02/13/20
02/13
16:10
02/13/20
16:10
MMNFF

MedMen

$0.00 /

+ (+0.00%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of MedMen with a Neutral rating.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
10/29/19 Roth Capital
MedMen downgraded to Neutral from Buy at Roth Capital
09/13/19
Fly Intel: Top five analyst initiations
On The Fly
Rising High: Tilray cuts 10% of staff as MedMen, WeedMD transition CEOs » 10:17
02/06/20
02/06
10:17
02/06/20
10:17
TLRY

Tilray

$17.83 /

+0.28 (+1.60%)

, MMNFF

MedMen

$0.00 /

+ (+0.00%)

, WDDMF

WeedMD

$0.00 /

+ (+0.00%)

, ACB

Aurora Cannabis

$2.12 /

+ (+0.00%)

, IIPR

Innovative Industrial Properties

$95.87 /

+0.825 (+0.87%)

, GTBIF

Green Thumb Industries

$0.00 /

+ (+0.00%)

, APHA

Aphria

$4.58 /

-0.02 (-0.44%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$1.01 /

-0.005 (-0.49%)

, CGC

Canopy Growth

$21.93 /

+0.28 (+1.29%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, CRON

Cronos Group

$7.36 /

+0.09 (+1.24%)

, IGC

India Globalization Capital

$0.64 /

+0.0072 (+1.14%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$5.12 /

+ (+0.00%)

In this week's "Rising…

Open Full Text

ShowHide Related Items >><<
TLRY Tilray
$17.83 /

+0.28 (+1.60%)

01/15/20 Jefferies
Tilray share rally on management changes overdone, says Jefferies
01/13/20
Fly Intel: Top five analyst initiations
01/13/20 BofA
BofA starts Tilray at Neutral with $18 price target
01/13/20 BofA
Tilray initiated with a Neutral at BofA
MMNFF MedMen
$0.00 /

+ (+0.00%)

12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
10/29/19 Roth Capital
MedMen downgraded to Neutral from Buy at Roth Capital
09/13/19
Fly Intel: Top five analyst initiations
WDDMF WeedMD
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$2.12 /

+ (+0.00%)

01/13/20 Cantor Fitzgerald
Aurora Cannabis selloff a buying opportunity, says Cantor Fitzgerald
01/10/20 BofA
Aurora Cannabis downgraded to Underperform from Neutral at BofA
01/09/20 Piper Sandler
Aurora Cannabis downgraded to Underweight from Neutral at Piper Sandler
01/02/20 Cantor Fitzgerald
Cantor says time for Peltz to call on Aurora to show financial discipline
IIPR Innovative Industrial Properties
$95.87 /

+0.825 (+0.87%)

11/06/19 BTIG
BTIG sees more opportunity ahead for Innovative Industrial Properties
06/20/19 BTIG
Innovative Industrial Properties price target raised to $148 from $101 at BTIG
03/20/19 Ladenburg
Innovative Industrial Properties downgraded to Neutral from Buy at Ladenburg
03/19/19 BTIG
Innovative Industrial Properties price target raised to $101 from $72 at BTIG
GTBIF Green Thumb Industries
$0.00 /

+ (+0.00%)

10/09/19 Craig-Hallum
Vaping crisis underscores need to lift cannabis prohibition, says Craig-Hallum
09/19/19 Alliance Global Partners
Green Thumb Industries initiated with a Buy at Alliance Global Partners
09/13/19 Cowen
Green Thumb Industries initiated with an Outperform at Cowen
APHA Aphria
$4.58 /

-0.02 (-0.44%)

01/15/20 CIBC
Aphria upgraded to Neutral from Underperformer at CIBC
01/13/20 BofA
Aphria initiated with a Neutral at BofA
01/06/20
Alphria vapes recall a 'major setback,' says Harvest Moon Research
CVSI CV Sciences
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
CTST CannTrust
$1.01 /

-0.005 (-0.49%)

07/12/19
CannTrust downgraded to Sell from Neutral at Eight Capital
07/09/19 Roth Capital
CannTrust downgraded to Neutral from Buy at Roth Capital
07/08/19
CannTrust downgraded to Neutral from Buy at Eight Capital
07/08/19 BofA
BofA double downgrades CannTrust to Underperform after Health Canada probe
CGC Canopy Growth
$21.93 /

+0.28 (+1.29%)

01/28/20 BMO Capital
BMO upgrades Canopy Growth to Outperform on potential sentiment shift
01/28/20 BMO Capital
Canopy Growth upgraded to Outperform from Market Perform at BMO Capital
01/10/20 Argus
Constellation Brands downgraded to Hold from Buy at Argus
12/12/19 Cantor Fitzgerald
Canopy Growth price target raised to C$27 from C$18.90 at Cantor Fitzgerald
CANN General Cannabis
$0.00 /

+ (+0.00%)

10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
06/10/19 Piper Sandler
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
CRON Cronos Group
$7.36 /

+0.09 (+1.24%)

01/17/20 Piper Sandler
Cronos opportunities in U.S. underappreciated by market, says Piper Sandler
10/22/19 Piper Sandler
Piper cuts targets in Cannabis, says Canopy and Cronos best positioned
10/18/19 Stifel
Cronos Group upgraded to Buy from Hold at Stifel
IGC India Globalization Capital
$0.64 /

+0.0072 (+1.14%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

12/16/19 Craig-Hallum
Trulieve Cannabis initiated with a Buy at Craig-Hallum
12/03/19 Needham
Trulieve Cannabis initiated with a Buy at Needham
12/02/19 Compass Point
Trulieve Cannabis upgraded to Buy from Neutral at Compass Point
ZYNE Zynerba
$5.12 /

+ (+0.00%)

12/31/19
Fly Intel: Top five analyst actions
12/31/19 Roth Capital
Zynerba assumed with a Buy at Roth Capital
12/16/19 Canaccord
Zynerba's Zygel may have 'clear place' as DEE treatment, says Canaccord
10/21/19 Needham
Zynerba initiated with a Buy at Needham
Hot Stocks
MedMen CEO Adam Bierman to step down » 10:26
01/31/20
01/31
10:26
01/31/20
10:26
MMNFF

MedMen

$0.00 /

+ (+0.00%)

MedMen Enterprises…

MedMen Enterprises announced that Adam Bierman, Co-Founder and CEO has decided to step down as CEO of the Company effective February 1, 2020. The board of directors of the Company is in the process of forming a committee of directors that will be responsible for identifying and appointing a new CEO. The committee expects to consider internal and external candidates and may engage a national search firm to aid in its efforts. In the interim, the board of directors has named the Company's COO & CTO, Ryan Lissack, as Interim CEO. Mr. Bierman has agreed to continue to serve on the Company's board of directors, including as part of the board to be elected at the Company's upcoming shareholder meeting. In addition, Mr. Bierman has agreed to surrender all of his Class A super voting shares back to the Company. As previously announced in December, MedMen Co-Founder Andrew Modlin granted a proxy over all of his Super Voting Shares to the Company's Executive Chairman, Ben Rose until December 2020. Mr. Modlin has also agreed to surrender all of his Super Voting Shares to the Company, which would occur upon the expiration of the proxy granted to Mr. Rose. As a result of the surrender of the Super Voting Shares, by the end of 2020, MedMen will have only one class of outstanding shares, the Class B subordinate voting share, each of which entitle the holder to one vote.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

12/17/19 Cowen
MedMen upgraded to Market Perform from Underperform at Cowen
11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
10/29/19 Roth Capital
MedMen downgraded to Neutral from Buy at Roth Capital
09/13/19
Fly Intel: Top five analyst initiations
Upgrade
MedMen upgraded to Market Perform from Underperform at Cowen » 07:50
12/17/19
12/17
07:50
12/17/19
07:50
MMNFF

MedMen

$0.00 /

+ (+0.00%)

Cowen analyst Vivien Azer…

Cowen analyst Vivien Azer upgraded MedMen to Market Perform from Underperform due to new corporate governance measures, further cost reductions, increased balance sheet flexibility, and explicit support from its financial sponsors. Azer raised her price target to $.75 from $.40 on MedMen shares.

ShowHide Related Items >><<
MMNFF MedMen
$0.00 /

+ (+0.00%)

11/27/19 Roth Capital
MedMen price target lowered to C$1.50 from C$2.00 at Roth Capital
10/29/19 Roth Capital
MedMen downgraded to Neutral from Buy at Roth Capital
09/13/19
Fly Intel: Top five analyst initiations
09/13/19 Cowen
MedMen initiated with an Underperform at Cowen

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.